Insider Transactions in Q1 2021 at Outset Medical, Inc. (OM)
Insider Transaction List (Q1 2021)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Mar 25
2021
|
Rebecca Chambers Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
16,727
-30.49%
|
$819,623
$49.64 P/Share
|
|
Mar 25
2021
|
Rebecca Chambers Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
16,727
+35.55%
|
$100,362
$6.25 P/Share
|
|
Mar 23
2021
|
Andrea Lynn Saia Director |
BUY
Grant, award, or other acquisition
|
Direct |
5,043
+50.0%
|
-
|
|
Mar 18
2021
|
John L. Brottem General Counsel |
SELL
Open market or private sale
|
Direct |
3,500
-9.8%
|
$168,000
$48.17 P/Share
|
|
Mar 18
2021
|
John L. Brottem General Counsel |
BUY
Exercise of conversion of derivative security
|
Direct |
3,500
+16.15%
|
$31,500
$9.48 P/Share
|
|
Mar 15
2021
|
Martin Vazquez Chief Operating Officer |
BUY
Grant, award, or other acquisition
|
Direct |
8,255
+47.14%
|
-
|
|
Mar 15
2021
|
Rebecca Chambers Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
13,597
+50.0%
|
-
|
|
Mar 15
2021
|
John L. Brottem General Counsel |
BUY
Grant, award, or other acquisition
|
Direct |
11,169
+43.22%
|
-
|
|
Mar 15
2021
|
Leslie Trigg Chair and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
87,412
+16.01%
|
-
|
|
Jan 08
2021
|
Karen Drexler Director |
BUY
Grant, award, or other acquisition
|
Direct |
5,383
+50.0%
|
-
|
|
Jan 05
2021
|
Warburg Pincus X, L.P. |
SELL
Open market or private sale
|
Indirect |
552,934
-10.46%
|
$27,646,700
$50.35 P/Share
|
|
Jan 05
2021
|
Warburg Pincus LLC |
SELL
Open market or private sale
|
Indirect |
552,934
-10.46%
|
$27,646,700
$50.35 P/Share
|